Loading…
Integra LifeSciences has made a binding offer to acquire the Codman Neurosurgery business from Johnson & Johnson for $1.045 billion in cash. The acquisition includes a portfolio of devices for hydrocephalus, neuro-critical care, and operative neurosurgery.